oro-antral fistula. Unspecified lesions of oral mucosa
Conditions
Interventions
Intervention 1: Intervention group: titanium mesh and buccal advancement flap. Intervention 2: Control group: buccal fat and buccal advancement.
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with OAF over 18 years, symptoms of maxillary sinusitis, ASA 1 and 2, OAF larger than 5 mm OLD (one month to 6 months after fistula)
Exclusion criteria
Exclusion criteria: Patients under 18 years, ASA above 2, previous failed treatments, history of microvascular and post-diabetes microvascular, metabolic bone disorders, history of renal failure, head and neck radiotherapy, patients under chemotherapy, pregnancy, drug or alcohol use, poor oral hygiene, periodontal disease, a gingival bleeding index above 20% maxillary fracture, presence of fixation devices or foreign bodies in the sinus, medication-related osteonecrosis of the jaw (MRONJ), or the presence of osteoradionecrosis. patients who refuse to participate in follow-up sessions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Wound dehiscence in clinical observation,. Timepoint: one-week, one-month, three-month, and six-month. Method of measurement: clinical observation.;Infection in clinical observation,. Timepoint: one-week, one-month, three-month, and six-month. Method of measurement: infection signs including edema, erythema, pus or hotness.;Swelling in clinical observation,. Timepoint: one-week, one-month, three-month, and six-month. Method of measurement: clinical evaluation.;Oro-antral fistula in clinical observation,. Timepoint: one-week, one-month, three-month, and six-month. Method of measurement: clinical evaluation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactPouria Javaheri
Shahid Beheshti University of Medical Sciences
Outcome results
None listed